ArticleMolecular neurobiology2025
Hypoxic Natural Killer Cells-Derived HIF-1α-Containing Exosomes Inhibit Cellular Senescence and Apoptosis in Neurocytes to Ameliorate Alzheimer's Disease by Eliminating Oxidative Damages.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Achilles' heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma.Journal of translational medicine · 2026Article
- Interleukin-Mediated Inflammatory Pathways and Nerve Injury in Lumbar Disc Herniation: A Narrative Review.International journal of general medicine · 2026Review
- Brain rewired: Redox control of brain cell crosstalk via nanotubes and vesicles.Free radical biology & medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As important immune cells in innate immunity, natural killer (NK) cells are closely associated with the progression of Alzheimer's disease (AD). Hypoxia has been considered as a critical factor that influences AD development, but the regulating effects and underlying mechanisms of hypoxic NK cells in AD progression have not been studied. Herein, our study illustrated that hypoxic NK cells-derived exosomes ameliorated AD progression by delivering hypoxia-inducible factor 1α (HIF-1α). Specifically, AD models APP/PS1 mice and β-amyloid (Aβ)-treated HT22 cells were subjected to exosomes from NK cells cultured under normoxic (Nor-exo) or hypoxic (Hyp-exo) conditions. Compared to Nor-exo, Hyp-exo alleviated mice cognition damage, reduced the levels of p-Tau, P16, and P53, and senescence-associated β-galactosidase (SA-β-Gal) to suppress cellular senescence, downregulated Bax and upregulated Bcl-2 to suppress apoptotic cell death, and decreased MDA levels and increased GSH/GSSG ratio to initiate anti-oxidant effects in both APP/PS1 mice brain tissues and Aβ-treated HT22 cells. Moreover, antioxidant N-acetyl-L-cysteine (NAC) obviously mitigated Aβ-triggered senescence and apoptosis in HT22 cells. Interestingly, our mechanical experiments confirmed that HIF-1α was especially enriched in Hyp-exo compared to Nor-exo, and the following rescue experiments verified that Hyp-exo exerted its protective effects in AD models by delivering HIF-1α. In conclusion, Hyp-exo HIF-1α-dependently suppressed oxidative stress-related neuronal cell senescence and apoptosis to mitigate pathogenesis of AD, and our study might provide new theoretical basis for developing treatment methods for AD.
Indexed as
Identifiers
40481944What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.